New Report Scrutinizes PBM Spread Pricing Practice
Findings from the study conducted by 3 Axis Advisors confirm that PBM practices have an impact on pharmacies.
Making Lemonade Out of Lemons: A Win-Win for Patients and Pharmacies Dispensing GLP-1s
With the high demand in GLP-1 medications, pharmacists are now living in an unprecedented time of filling prescriptions for high-cost brand-name drugs.
Maximize Disease Awareness Months in the Pharmacy
Make every month a celebration of wellbeing at the pharmacy by leveraging disease awareness initiatives.
Student, Staffing Shortages Continue to Impact Pharmacy Profession
The COVID-19 pandemic led to increased pharmacist burnout and workforce shortages. The impact is still being felt today.
Use Your Voice: Pharmacists as Patient Advocates
From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.
In This Issue: Total Pharmacy August 2024
See what’s trending in pharmacy with a preview of the Total Pharmacy August issue.
In July, PBMs Found Themselves in the Federal Government Hot Seat
An interim FTC report outlined how the rise of vertical integration and concentration has led to devastating results for both patients and fragile pieces of the health care delivery system.
Strategies for Pharmacy Success: Navigating the Evolving Healthcare Landscape and Unlocking Alternate Revenue Streams
Emily Endres, BSPS, vice president of pharmacy at Innovaccer discuss the evolution of healthcare and provides insights into the industry’s next phase.
Taking Care of Transparency in Drug Pricing, So Pharmacy Can Take Care of Patients
Erin Albert, Vice President of Pharmacy Relations and Chief Privacy Officer at Mark Cuban Cost Plus Drug Company, PBC, discussed the changing landscape regarding prescription drug pricing.
Front-Line Impacts of Point-of-Sale DIR Fees on Community Pharmacies: Mid-Year Update with AAP
A roundtable session discussed the real-world implications of applying Direct and Indirect Remuneration (DIR) fees at the point of sale rather than through retroactive clawback.
Elevate and Thrive: Increasing Pharmacy Profits with MTM and Patient Engagements Solutions
Lauren Adair, PharmD, director of network enablement at Outcomes, discussed developments in the expanding role of pharmacists amidst rising health care costs.
Maximizing Pharmacy Revenue Potential: The Benefits of Mobile Checkout
Jon Minkin, Enterprise Account Executive at NimbleRx and pharmacy technology expert, discussed how his company can help independent pharmacies unlock revenue opportunities.
Democrats, Republicans Come Together to Condemn PBMs
In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.
NCPA Representative Discusses Role in Influencing PBM Reform
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.
PBM Reform Law Aims to Support Local Pharmacies in Pennsylvania
House Bill (HB) 1993 seeks to increase PBM transparency and accountability in an effort to combat the rising cost of prescription drugs.
How Pharmacies Should Prepare as the DSCSA Stabilization Period Ends
As the end of the DSCSA stabilization period approaches, Scott Mooney, vice president of distribution operations at McKesson, discussed what pharmacists should consider to be prepared.
McKesson ideaShare 2024 Recap
Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.
As Pharmacies Face Financial Distress, RxOwnership Uses Data to Increase Profits
Chris Cella, RPh, vice president of RxOwnership at McKesson, talks about how independent pharmacies can help improve their bottom line.
Pharmacies Can Improve Front End Sales with Foster & Thrive OTC Products
McKesson’s private brand of OTC health and wellness products are a great way for independent pharmacies to increase profits.
Maximizing Reimbursement With McKesson Solutions
Emily Flaugher, Vice President and General Manager of Health Mart Atlas and Atlas Specialty at McKesson, sat down with Drug Topics to discuss McKesson solutions that help independent pharmacists maximize reimbursement.
Breaking Down Return Solutions’ Rx Returns Process with Jeremy Cundiff
Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.
Is LTC Pharmacy Going Back to the Future?
Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.
Wrapping Up McKesson ideaShare 2024
Drug Topics has been on site at McKesson ideaShare this week! Check out this podcast to hear a few of the things we've experienced and what we've learned so far.
ICYMI: Total Pharmacy June 2024 Issue
Don’t miss out on the latest pharmacy insights in the Total Pharmacy June issue.
Unlock the Power of Digital Marketing for Independent Pharmacies
During a session at McKesson ideaShare 2024, Martin Dennis of RxOwnership was joined by digital marketing experts to discuss key marketing tools for independent pharmacies.
Welcome to McKesson ideaShare
Drug Topics has been on site at McKesson ideaShare this week. Check out this podcast to hear a few of the exciting happenings at this year’s meeting.
Register Today: July 2024 Total Pharmacy Solutions Summit
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
In This Issue: Total Pharmacy June 2024
See what’s trending in pharmacy with a preview of the Total Pharmacy June issue.
How to Improve Medication Adherence Within the Pharmacy
Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.